The percentage of distribution in the European Union of this vaccine exceeds 70% of the total.
While in most of the world the population awaited, with confinement included, the arrival of a vaccine to avoid contracting COVID-19 or, at least, reduce its harmful effects, laboratories … + read more
Pfizer’s vaccine has been the most administered in Europe
The percentage of distribution in the European Union of this vaccine exceeds 70% of the total. + read more
Pfizer’s revenue soars thanks to coronavirus
Pfizer expects to bill more than 98 billion dollars in 2022. The American company doubled its turnover in 2021 thanks to the covid19 vaccine and they expect great results from their oral medication for the treatment of the Paxlovid virus. + read more
Pfizer/BioNTech Seeks US Approval of a Modified Covid-19 Booster
Pharmaceutical companies have asked the US Administration to authorize their reformulated booster vaccine. + read more
Pfizer increases profit by 78% in the second quarter
The American laboratory Pfizer raises its benefits to 9,755 million. + read more
mRNA vaccines perform better against worrisome variants of Covid-19
mRNA vaccines, such as Pfizer and Moderna, are more effective against worrisome variants of Covid-19. + read more
The EMA evaluates the Pfizer vaccine adapted to the variants
Pfizer and BioNTech are evaluating several variant-adapted vaccines of the virus. + read more
